| 0 (0%) | 04-18 13:42 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 156  |
1-year : | 163.96 |
| Resists | First : | 133.56 |
Second : | 140.38 |
| Pivot price | 126.8 |
|||
| Supports | First : | 122.54 |
Second : | 101.95 |
| MAs | MA(5) : | 123.56 |
MA(20) : | 128.43 |
| MA(100) : | 128.76  |
MA(250) : | 118.36 |
|
| MACD | MACD : | -2.3 |
Signal : | -1.7 |
| %K %D | K(14,3) : | 3.8 |
D(3) : | 5.2 |
| RSI | RSI(14): 34 |
|||
| 52-week | High : | 141.77 | Low : | 95.12 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ GPN ] has closed above bottom band by 19.3%. Bollinger Bands are 23.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 125.1 - 125.93 | 125.93 - 126.68 |
| Low: | 120.68 - 121.75 | 121.75 - 122.71 |
| Close: | 121.8 - 123.46 | 123.46 - 124.96 |
Wed, 03 Apr 2024
PGN Ensures Earth Gas Services Are Safe During Eid Al-Fitr 1445 H - VOI English
Wed, 13 Mar 2024
PepGen Receives U.S. FDA Orphan Drug and Rare Pediatric Disease Designations for PGN-EDO51 for the Treatment ... - GlobeNewswire
Wed, 06 Mar 2024
Conrad Asia Inks MoU with PGN for Gas Development Offshore Indonesia - Rigzone News
Tue, 20 Feb 2024
PepGen Receives U.S. FDA Fast Track Designation for PGN-EDODM1 for the Treatment of Myotonic Dystrophy Type 1 - Yahoo Finance
Tue, 06 Feb 2024
Höegh LNG resolves legal dispute over PGN FSRU Lampung - Splash247 - Splash 247
Tue, 06 Feb 2024
Indonesia's PGN, Hoegh LNG settle Lampung FSRU dispute - LNG Prime
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 255 (M) |
| Shares Float | 255 (M) |
| Held by Insiders | 0.8 (%) |
| Held by Institutions | 92.8 (%) |
| Shares Short | 6,710 (K) |
| Shares Short P.Month | 6,780 (K) |
| EPS | 3.76 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 88.33 |
| Profit Margin | 10.2 % |
| Operating Margin | 24.5 % |
| Return on Assets (ttm) | 2.9 % |
| Return on Equity (ttm) | 4.4 % |
| Qtrly Rev. Growth | 8 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 37.83 |
| EBITDA (p.s.) | 15.64 |
| Qtrly Earnings Growth | 49.4 % |
| Operating Cash Flow | 2,250 (M) |
| Levered Free Cash Flow | 2,310 (M) |
| PE Ratio | 32.61 |
| PEG Ratio | 0.7 |
| Price to Book value | 1.39 |
| Price to Sales | 3.24 |
| Price to Cash Flow | 13.93 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|